Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E VOSS

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitorsRobert J Cherney, James J-W Duan, Matthew E Voss, et al.
Cell Reports|August 23, 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing AntibodiesLaura E McCoy, Marit J van Gils, Gabriel Ozorowski, et al.
EMBO Reports|May 24, 2022
Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteinsSouheyla Benfrid, Kyu-Ho Park, Mariano Dellarole, et al.
Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Nature Communications|December 19, 2018
Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in miceLaura A Hancock, Corinne E Hennessy, George M Solomon, et al.
Pathogens & Immunity|October 27, 2025
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025Kiho Tanaka, Tatenda Jimmy Blessing Chikowore, Steven G Deeks, et al.
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2020
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse modelsDeli Huang, Robert K Abbott, Colin Havenar-Daughton, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitorsRobert J Cherney, James J-W Duan, Matthew E Voss, et al.
Cell Reports|August 23, 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing AntibodiesLaura E McCoy, Marit J van Gils, Gabriel Ozorowski, et al.
EMBO Reports|May 24, 2022
Dengue virus NS1 protein conveys pro-inflammatory signals by docking onto high-density lipoproteinsSouheyla Benfrid, Kyu-Ho Park, Mariano Dellarole, et al.
Nature Communications|August 8, 2024
Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypesVaradha Balaji Venkadakrishnan, Adam G Presser, Richa Singh, et al.
Nature Communications|December 19, 2018
Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in miceLaura A Hancock, Corinne E Hennessy, George M Solomon, et al.
Pathogens & Immunity|October 27, 2025
Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025Kiho Tanaka, Tatenda Jimmy Blessing Chikowore, Steven G Deeks, et al.
Mabs|March 5, 2014
Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CAJuan Carlos Almagro, Gary L Gilliland, Felix Breden, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2020
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse modelsDeli Huang, Robert K Abbott, Colin Havenar-Daughton, et al.
Biorxiv : the Preprint Server for Biology|November 25, 2020
An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19C Garrett Rappazzo, Longping V Tse, Chengzi I Kaku, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal modelThomas F Rogers, Fangzhu Zhao, Deli Huang, et al.
Pageof 16